Vanguard Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,625,091
| Closed | -$17.1M | – | 4333 |
|
|
2024
Q4 | $17.1M | Sell |
5,625,091
-108,608
| -2% | -$330K | ﹤0.01% | 2655 |
|
|
2024
Q3 | $29.8M | Sell |
5,733,699
-260,760
| -4% | -$1.35M | ﹤0.01% | 2403 |
|
|
2024
Q2 | $15.4M | Buy |
5,994,459
+596,053
| +11% | +$1.53M | ﹤0.01% | 2696 |
|
|
2024
Q1 | $26.6M | Buy |
5,398,406
+328,781
| +6% | +$1.62M | ﹤0.01% | 2455 |
|
|
2023
Q4 | $44.6M | Buy |
5,069,625
+278,166
| +6% | +$2.45M | ﹤0.01% | 2235 |
|
|
2023
Q3 | $55M | Buy |
4,791,459
+138,683
| +3% | +$1.59M | ﹤0.01% | 2084 |
|
|
2023
Q2 | $118M | Buy |
4,652,776
+53,031
| +1% | +$1.34M | ﹤0.01% | 1764 |
|
|
2023
Q1 | $148M | Buy |
4,599,745
+103,429
| +2% | +$3.33M | ﹤0.01% | 1616 |
|
|
2022
Q4 | $83M | Buy |
4,496,316
+183,420
| +4% | +$3.39M | ﹤0.01% | 1908 |
|
|
2022
Q3 | $116M | Buy |
4,312,896
+609,841
| +16% | +$16.5M | ﹤0.01% | 1693 |
|
|
2022
Q2 | $51.2M | Buy |
3,703,055
+57,744
| +2% | +$798K | ﹤0.01% | 2183 |
|
|
2022
Q1 | $71.1M | Buy |
3,645,311
+43,014
| +1% | +$839K | ﹤0.01% | 2120 |
|
|
2021
Q4 | $58.8M | Buy |
3,602,297
+17,392
| +0.5% | +$284K | ﹤0.01% | 2259 |
|
|
2021
Q3 | $99.9M | Sell |
3,584,905
-27,843
| -0.8% | -$776K | ﹤0.01% | 1980 |
|
|
2021
Q2 | $107M | Buy |
3,612,748
+69,654
| +2% | +$2.06M | ﹤0.01% | 1965 |
|
|
2021
Q1 | $99M | Buy |
3,543,094
+302,923
| +9% | +$8.47M | ﹤0.01% | 1949 |
|
|
2020
Q4 | $91.8M | Buy |
3,240,171
+87,795
| +3% | +$2.49M | ﹤0.01% | 1867 |
|
|
2020
Q3 | $79.3M | Buy |
3,152,376
+257,993
| +9% | +$6.49M | ﹤0.01% | 1799 |
|
|
2020
Q2 | $70.7M | Buy |
2,894,383
+224,934
| +8% | +$5.49M | ﹤0.01% | 1832 |
|
|
2020
Q1 | $39.5M | Buy |
2,669,449
+139,403
| +6% | +$2.06M | ﹤0.01% | 1978 |
|
|
2019
Q4 | $41.1M | Buy |
2,530,046
+380,567
| +18% | +$6.18M | ﹤0.01% | 2204 |
|
|
2019
Q3 | $27.9M | Sell |
2,149,479
-99,665
| -4% | -$1.3M | ﹤0.01% | 2314 |
|
|
2019
Q2 | $29.2M | Buy |
2,249,144
+146,444
| +7% | +$1.9M | ﹤0.01% | 2351 |
|
|
2019
Q1 | $33.1M | Buy |
2,102,700
+358,343
| +21% | +$5.65M | ﹤0.01% | 2284 |
|
|
2018
Q4 | $35.1M | Buy |
1,744,357
+237,562
| +16% | +$4.78M | ﹤0.01% | 2197 |
|
|
2018
Q3 | $37.4M | Buy |
1,506,795
+28,683
| +2% | +$713K | ﹤0.01% | 2291 |
|
|
2018
Q2 | $40.6M | Buy |
1,478,112
+155,595
| +12% | +$4.27M | ﹤0.01% | 2238 |
|
|
2018
Q1 | $40.7M | Buy |
1,322,517
+81,914
| +7% | +$2.52M | ﹤0.01% | 2175 |
|
|
2017
Q4 | $44.4M | Buy |
1,240,603
+216,268
| +21% | +$7.73M | ﹤0.01% | 2122 |
|
|
2017
Q3 | $28.2M | Buy |
1,024,335
+92,712
| +10% | +$2.55M | ﹤0.01% | 2326 |
|
|
2017
Q2 | $24.6M | Buy |
931,623
+63,505
| +7% | +$1.68M | ﹤0.01% | 2366 |
|
|
2017
Q1 | $18.1M | Buy |
868,118
+42,466
| +5% | +$883K | ﹤0.01% | 2483 |
|
|
2016
Q4 | $17.1M | Buy |
825,652
+13,829
| +2% | +$286K | ﹤0.01% | 2486 |
|
|
2016
Q3 | $13.2M | Buy |
811,823
+28,117
| +4% | +$456K | ﹤0.01% | 2550 |
|
|
2016
Q2 | $10.7M | Buy |
783,706
+79,366
| +11% | +$1.08M | ﹤0.01% | 2615 |
|
|
2016
Q1 | $12.3M | Buy |
704,340
+51,330
| +8% | +$896K | ﹤0.01% | 2498 |
|
|
2015
Q4 | $22.3M | Buy |
653,010
+170,398
| +35% | +$5.82M | ﹤0.01% | 2264 |
|
|
2015
Q3 | $14.4M | Buy |
482,612
+34,155
| +8% | +$1.02M | ﹤0.01% | 2429 |
|
|
2015
Q2 | $14.3M | Buy |
448,457
+30,685
| +7% | +$981K | ﹤0.01% | 2498 |
|
|
2015
Q1 | $8.66M | Buy |
417,772
+33,874
| +9% | +$702K | ﹤0.01% | 2713 |
|
|
2014
Q4 | $6.5M | Buy |
383,898
+65,636
| +21% | +$1.11M | ﹤0.01% | 2755 |
|
|
2014
Q3 | $6.15M | Buy |
318,262
+90,236
| +40% | +$1.74M | ﹤0.01% | 2723 |
|
|
2014
Q2 | $7.75M | Buy |
228,026
+93,138
| +69% | +$3.17M | ﹤0.01% | 2632 |
|
|
2014
Q1 | $4.25M | Buy |
+134,888
| New | +$4.25M | ﹤0.01% | 2914 |
|